Eventual Role of Chemotherapy in CLL with Dr. Steven Coutre
The eventual role chemotherapy will play in the treatment of chronic lymphocytic leukemia (CLL) Steven Coutre, MD, professor of Medicine (Hematology), Stanford University Medical Center Author: onclivetv Added: 06/19/2015 (Source: Oncology Tube)
Source: Oncology Tube - June 19, 2015 Category: Cancer & Oncology Source Type: podcasts

The Emotions of Watch and Wait
The watch and wait process can be a challenging and stressful time for chronic lymphocytic leukemia patients and their families. Licensed psychologist Dr. Rena Szabo shares with us how her team and th... Author: patientpower Added: 06/18/2015 (Source: Oncology Tube)
Source: Oncology Tube - June 18, 2015 Category: Cancer & Oncology Source Type: podcasts

EHA 2015: Venetoclax (ABT-199/GDC-0199) combined with rituximab induces deep responses in patients with relapsed/refractory CLL
In a phase 1b, open-label, dose-escalation, multicentre study of patients with relapsed or refractory chronic lymphocytic leukaemia (CLL), the combination of the BCL-2 inhibitor, venetoclax (ABT-199/G... Author: EMJ Added: 06/13/2015 (Source: Oncology Tube)
Source: Oncology Tube - June 13, 2015 Category: Cancer & Oncology Source Type: podcasts

Clinical Trial Access for Canadian CLL Patients
At the 2015 CLL Live conference in Niagara Falls, Andrew Schorr caught up with Dr. Ronan Foley, as he explores Canadian patient access to clinical trials for chronic lymphocytic leukemia (CLL). Dr. Fo... Author: patientpower Added: 06/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - June 11, 2015 Category: Cancer & Oncology Source Type: podcasts

ASCO 2015: New Ibrutinib Combination Regimen Shows Substantial Benefits in Relapsed Chronic Lymphocytic Leukemia
An interim analysis of a large phase III study suggests that the combination of ibrutinib and bendamustine/rituximab (BR) improves outcomes for patients with chronic-lymphocytic leukemia (CLL) that wo... Author: EMJ Added: 06/03/2015 (Source: Oncology Tube)
Source: Oncology Tube - June 3, 2015 Category: Cancer & Oncology Source Type: podcasts

Ask the CLL doctor video series with Dr Claire Dearden (Part 3)
Dr Claire Dearden, Consultant Haematologist and Head of the Chronic Lymphocytic Leukaemia (CLL) Unit at The Royal Marsden and The Institute of Cancer Research, answers questions about: • Ibrutinib ... Author: PatientPowerEU Added: 06/01/2015 (Source: Oncology Tube)
Source: Oncology Tube - June 1, 2015 Category: Cancer & Oncology Source Type: podcasts

Ibrutinib Resistance in CLL
Resistance to ibrutinib in patients with chronic lymphocytic leukemia (CLL). William G. Wierda, MD, PhD, medical director, Leukemia Center, The University of Texas MD Anderson Cancer Center, Author: onclivetv Added: 05/27/2015 (Source: Oncology Tube)
Source: Oncology Tube - May 27, 2015 Category: Cancer & Oncology Source Type: podcasts

Understanding Oncogenes in CLL
What is a genetic mutation? What are the different types that are associated with chronic lymphocytic leukemia (CLL)? CLL experts Drs. Alessandra Ferrajoli, Nitin Jain and Javier Munoz discuss oncogen... Author: patientpower Added: 05/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - May 23, 2015 Category: Cancer & Oncology Source Type: podcasts

Advice for Coping with a CLL Relapse
A therapist from Ontario, Canada, Mark Silverstein, underwent FCR (fludarabine, cyclophosphamide, rituximab) to treat his chronic lymphocytic leukemia in 2011. Now with signs of a relapse, Mark may be... Author: patientpower Added: 05/13/2015 (Source: Oncology Tube)
Source: Oncology Tube - May 14, 2015 Category: Cancer & Oncology Source Type: podcasts

What Are Monoclonal Antibodies?
What are monoclonal antibodies? How do they work to treat chronic lymphocytic leukemia (CLL)? A CLL expert from MD Anderson Cancer Center, Dr. Alessandra Ferrajoli, explains this class of drugs and ho... Author: patientpower Added: 05/05/2015 (Source: Oncology Tube)
Source: Oncology Tube - May 5, 2015 Category: Cancer & Oncology Source Type: podcasts

George and Sandra Smith: We Don’t Let CLL Dominate Our Life
George Smith has lived with chronic lymphocytic leukemia (CLL) for more than 15 years, and he and his wife Sandra have learned how to not let the disease dominate their life together. Sandra and Georg... Author: patientpower Added: 04/21/2015 (Source: Oncology Tube)
Source: Oncology Tube - April 21, 2015 Category: Cancer & Oncology Source Type: podcasts

Understanding Common CLL Symptoms
What are chronic lymphocytic leukemia (CLL) symtpoms? Drs. Alessandra Ferrajoli, Nitin Jain and Javier Munoz, discuss common symptoms—including night sweats, swollen lymph nodes and fatigue—that peopl... Author: patientpower Added: 04/21/2015 (Source: Oncology Tube)
Source: Oncology Tube - April 21, 2015 Category: Cancer & Oncology Source Type: podcasts

Phase III Study of Idelalisib /Rituximab for Relapsed Chronic Lymphocytic Leukemia
Dr. Jeff Sharman analysis of a phase 3 study of idelalisib plus rituximab for relapsed chronic lymphocytic leukemia: efficacy analysis in patient subpopulations with Del(17p) and other adverse prognos... Author: feeds Added: 04/15/2015 (Source: Oncology Tube)
Source: Oncology Tube - April 15, 2015 Category: Cancer & Oncology Source Type: podcasts

Susan Novick: Everyone Has a Different CLL Journey
Susan Novick, diagnosed with chronic lymphocytic leukemia (CLL) in 2006, had never heard of the disease. Now, Susan joins Patient Power to discuss her journey through diagnosis and treatment. Learn wh... Author: patientpower Added: 04/13/2015 (Source: Oncology Tube)
Source: Oncology Tube - April 14, 2015 Category: Cancer & Oncology Source Type: podcasts

Dr. La Verne Abe Harris: CLL Doesn’t Define Me
When patient advocate and blogger Dr. La Verne Abe Harris was diagnosed with chronic lymphocytic leukemia in 2009, she was initially told that she would not live more than two or three years. Now in c... Author: patientpower Added: 04/09/2015 (Source: Oncology Tube)
Source: Oncology Tube - April 10, 2015 Category: Cancer & Oncology Source Type: podcasts